The NYSGRC: A Large Scale Center for PSI:Biology
The NYSGRC: A Large Scale Center for PSI:Biology
批准号:
8330267
负责人:
STEVEN C. ALMO
金额:
$663.45万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2015-06-30
关键词:
AddressAlgorithmsArchivesAreaAutoimmune DiseasesAutomobile DrivingBiochemicalBiochemistryBioinformaticsBiologicalBiologyBiotechnologyCaliforniaCaringCell LineCell membraneCellular biologyChargeCommitCommunicable DiseasesCommunitiesComplementComplexCoupledCryoelectron MicroscopyCrystallizationDataData CollectionDatabasesDepositionDevelopmentDiseaseElementsEnsureEnzymesEukaryotic CellEvolutionFailureFamilyFundingFutureGenerationsGeneticHealthHomology ModelingHumanHuman ResourcesHybridsIllinoisImmuneIndividualInformaticsInformation DisseminationInsectaInternationalLabelLaboratoriesLeadershipLengthLettersLigand BindingLightLinkMalignant NeoplasmsManualsMedicalMedicineMembrane ProteinsMethodsMissionModelingModificationMolecularNMR SpectroscopyNational Institute of General Medical SciencesNeoplasm MetastasisNew YorkNew York CityNuclear PoreOrthologous GenePathogenesisPharmaceutical PreparationsPhosphoric Monoester HydrolasesPhotonsPlayPositioning AttributePrincipal InvestigatorProcessProductionProductivityProgram Research Project GrantsProtein Structure InitiativeProteinsProtocols documentationQuality ControlRecordsRelianceReportingResearchResearch InfrastructureResearch PersonnelResolutionResourcesRoboticsRoentgen RaysRoleRunningSan FranciscoScreening procedureSeleniumSeriesServicesSesame - dietaryShapesSignal PathwaySolutionsSourceSpecimenSpeedStructural ModelsStructureSupervisionSystemTechnologyTertiary Protein StructureTherapeuticTimeTriageUnited States National Institutes of HealthUniversitiesVisionWashingtonWorkWritingbasebeamlinecollegecombatdata managementdata structuredesigndesign and constructionenzyme structureexperienceexpression cloningextracellularflexibilityinnovationinsightknowledge basemacromoleculemedical schoolsmeetingsmembermetropolitannanomachinenovelnovel strategiespathogenprogramsprospectusesprotein complexprotein expressionprotein structurerepositoryrestraintstructural biologysuccesstechnology developmenttherapeutic developmenttumoruser-friendlyward
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The NYSGRC has a 10-year proven track record in high-throughput structure determination as well as in discovering and implementing infrastructure to increase the speed, accuracy, success rate and affordability of structural biology studies. Moving forward the NYSGRC will reorganize to meet the new and diverse challenges associated with the PSI:Biology Network. In addition to reliance on traditional high-throughput bacterial expression platforms, the NYSGRC will develop and implement cutting-edge experimental and computational technologies to examine the biologically important molecules that are the focus of PSI:Biology. These targets are likely to include multidomain eukaryotic proteins, multi-component assemblies, and secreted proteins that underlay complex multi-cellular biology and directly contribute to human health and disease. In addition to servicing the High-Throughput-Enabled Structural Biology Partnerships, this infrastructure will support our Biological Theme that focuses on the secretion machinery and secreted effector proteins from major bacterial, protozoan and fungal pathogens. These targets were specifically selected to provide new insights into the mechanisms that these pathogens have evolved for immune evasion and modulation of host signaling pathways. These processes rely on intricate nano-machines, with cytoplasmic, membrane-associated and extracellular components, that require hybrid computational and experimental approaches to define their organization, structure and function. Finally, our integrated experimental and computational efforts have identified new opportunities to significantly and economically enhance sequence/structure coverage.
The advent of PSI:Biology is driving a process of evolutionary change for the NYSGRC that has already enhanced its outstanding high-throughput structure determination pipeline. Our strengths in traditional bacterial expression, coupled with novel approaches to eukaryotic expression and refolding, as well as our established expertise in hybrid methods, positions us to uniquely support the efforts of PSI:Biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10834306
-
项目类别:
-
资助金额:$9.93万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10548600
-
项目类别:
-
资助金额:$84.0万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10807389
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Amplifying and Redirecting CMV-specific CD8 T cells to provide sustained control of HIV infection
-
批准号:10634689
-
项目类别:
-
资助金额:$84.0万
-
财政年份:2022
-
负责人:STEVEN C. ALMO
-
依托单位:
Cancer Therapuetics
-
批准号:10429332
-
项目类别:
-
资助金额:$3.27万
-
财政年份:2021
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:9752177
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:10596609
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:9908044
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Biologics Designed to Mobilize HIV-specific CTL for Sustained HIV Remission
-
批准号:10375382
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2019
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells
-
批准号:10335165
-
项目类别:
-
资助金额:$71.58万
-
财政年份:2018
-
负责人:STEVEN C. ALMO
-
依托单位:
Function and Mechanism of Viperin, a radical SAM antiviral protein
-
批准号:9375148
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2017
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural basis of allostery and mechanical properties of F-actin
-
批准号:9322344
-
项目类别:
-
资助金额:$56.54万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9489077
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Structural basis of allostery and mechanical properties of F-actin
-
批准号:9749981
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:10003466
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9106970
-
项目类别:
-
资助金额:$52.06万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
Novel Strategies for Precision T-cell Therapies
-
批准号:9926079
-
项目类别:
-
资助金额:$52.06万
-
财政年份:2016
-
负责人:STEVEN C. ALMO
-
依托单位:
An integrated X-ray data collection system
-
批准号:9145388
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
Technologies for Mapping the Extracellular Interactome
-
批准号:9868371
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
Technologies for Mapping the Extracellular Interactome
-
批准号:8887877
-
项目类别:
-
资助金额:$64.8万
-
财政年份:2015
-
负责人:STEVEN C. ALMO
-
依托单位:
海外基金